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Abstract The simultaneous presence of hepatitis B virus (HBV)
genomes carrying wild-type (wt) and in-frame deleted variants of
the HBV core gene has been identified as a typical feature of
HBV-infected renal transplant patients with severe liver disease.
To investigate possible interactions of wt and deleted core
polypeptides a two-vector Escherichia coli expression system
ensuring their concomitant synthesis has been developed. Co-
expression of wt and a mutant core lacking 17 amino acid
residues (77^93) within the immunodominant region led to the
formation of mosaic particles, whereas the mutant alone was
incapable of self-assembly. ß 2000 Federation of European
Biochemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
With regard to their employment as carriers of foreign epi-
topes in vaccine development, core particles of hepatitis B
virus (HBV) have been well characterized by biochemical
and immunological methods during the last years [1^4]. The
HBV core particle is composed of homodimers that can be
stabilized by disul¢de links between the Cys61 residues in two
monomers [5,6]. Recently, the crystal structure of the T = 4
HBV core particle has been solved at 3.3 Aî resolution, reveal-
ing its composition of dimers with protruding spikes com-
posed of a four-helix bundle, the tip of them representing
the immunodominant region [7]. According to epitope map-
ping data, amino acid (aa) residues crucial for formation of
the immunodominant region lie within the Gly73^Gly94
stretch of the core polypeptide (for references see [4]). Clinical
studies have demonstrated that the emergence and accumula-
tion of mutated HBV genomes carrying deletions in the cen-
tral region of the HBV core gene (C gene) are accompanied by
the progression of liver disease in long-term immunosup-
pressed renal transplant recipients [8,9]. During immunosup-
pression such mutated HBV genomes seem to have a selective
advantage for replication over wild-type (wt) genomes [8,10]
and can represent up to 90% of the total HBV DNA popu-
lation in patient sera (unpublished data). Preferential appear-
ance of such C gene mutants during immunosuppression
makes their possible relation to immune escape mechanisms
unlikely.
To understand the folding and particle assembly properties
of mutated core polypeptides, the expression of a set of de-
leted C genes has been undertaken in Escherichia coli [11]. As
a result, the majority of mutated core polypeptides with dele-
tions protruding from Gly73 in the N-terminal direction and
from Gly94 in the C-terminal direction, respectively, was in-
capable of correct folding and self-assembly. In agreement
with this, deleted core polypeptides were not found within
infected hepatocytes (unpublished data). Recent data from
eukaryotic in vitro systems support these results ; after trans-
fection of hepatoma-derived cell lines with HBV genomes
carrying in-frame C gene deletions, no corresponding deleted
core derivatives could be detected [12,13].
However, it remained to be elucidated whether core dele-
tion variants could co-assemble with wt core polypeptides to
form mosaic particles consisting of di¡erent homo- and/or
heterodimers as subunits [3]. The simultaneous presence of
wt HBV genomes and virus variants carrying C gene deletions
in the sera and liver of immunosuppressed patients over long
periods [8,9] could re£ect a functional interaction with possi-
ble pathophysiological consequences.
In the work presented here, the simultaneous expression of
wt and mutated forms of the C gene in E. coli was investi-
gated. Using a two-vector expression system, the interaction
of wt with a mutant core polypeptide #77/93 carrying a dele-
tion of 17 aa residues (positions 77^93) was demonstrated.
This interaction leads to the formation of mosaic particles
within the bacterial cell, whereas the mutant #77/93 polypep-
tide alone is incapable of self-assembly.
2. Materials and methods
2.1. Construction of expression vectors
Full-length HBV genomes were ampli¢ed from sera and liver sam-
ples of patients with severe liver disease followed by cloning and
sequencing as described earlier [14]. C gene fragments carrying dele-
tions of 8, 17, 21 and 30 codons (designated as #86/93, #77/93, #75/95
and #82/111, respectively, according to the positions of codons de-
leted) were expressed in E. coli under the control of tandem trypto-
phan promoters. For that purpose, ColE1-replicon-based expression
plasmids pHBc3 (for expression of full-length core polypeptide as
‘long form’, aa 1^183) [15] and pT31 (for expression of C-terminally
truncated core polypeptide as ‘short form’, aa 1^144) [16] (Fig. 1)
were used. To ensure simultaneous synthesis of both wt and deleted
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core proteins within the same cell, a two-vector system was developed
using the compatible p15A-replicon-based vector pREP4 (Qiagen,
Hilden, Germany) in combination with ColE1-replicon-derived plas-
mids (Fig. 1).
2.2. Extraction and puri¢cation of core particles
The synthesis of wt and deleted core polypeptides was directed by
the expression/co-expression of the appropriate C gene variants from
ColE1- and/or p15A-replicon plasmids in the E. coli strain K802. For
co-expression experiments, deleted C genes were expressed in long and
short form from pREPc3 and pREPpT, respectively, whereas wt-C
genes were expressed from pBR-based plasmids pHBc3 or pT31. For
co-expression of both (short and long) wt core genes, plasmids pHBc3
and pREPpT were used. Cells were grown and lysed as described
earlier [11]. Core particles were puri¢ed by ammonium sulfate precip-
itation and by subsequent sucrose gradient (20^50%) centrifugation.
2.3. SDS^PAGE and immunoblotting
Sample preparation and sodium dodecyl sulfate^polyacrylamide gel
electrophoresis (SDS^PAGE; 15%) were done according to Laemmli
[17]. Western blotting was performed as described by Towbin et al.
[18]. Core proteins were detected with the monoclonal anti-HBc/HBe
antibody 239F5 (Sorin Biomedical, Saluggia, Italy) recognizing a re-
gion between aa 130^140 and anti-mouse IgG peroxidase conjugate
(Dako Diagnostika, Hamburg, Germany).
2.4. Electron microscopy
Sucrose gradient fractions were investigated by electron microscopy
of uranyl acetate negative contrasted samples as described by Gelder-
blom et al. [19] using a Zeiss EM 10A electron microscope.
2.5. Immunoprecipitation
Immunoprecipitation was carried out by overnight incubation of
puri¢ed core particles with the monoclonal antibody C1-5 (recogniz-
ing aa 78^83) [20] coupled to protein A-Sepharose CL-4B (Amersham
Pharmacia Biotech, Freiburg, Germany) at 4‡C on a rotary shaker.
After washing three times with TNE bu¡er (0.02 M Tris, 0.15 M
NaCl, 0.01 M EDTA, pH 8.0), the Sepharose-bound material was
eluted with Laemmli SDS-sample bu¡er containing 5% L-mercapto-
ethanol. Sepharose-unbound material was pooled and concentrated
from washing bu¡er by ammonium sulfate precipitation, before sol-
ubilization in SDS-sample bu¡er.
2.6. Cross-linking of dimers
To cross-link non-covalently connected core monomers by the in-
termolecular disul¢de bridge of Cys61 residues located at the dimer
interface, CuSO4 was used as an oxidizing agent in a procedure ac-
cording to Nassal et al. [5]. Portions of puri¢ed particles were mixed
with various amounts of a 1 mM CuSO4 stock solution to determine
the optimal Cu2 concentrations necessary for visualization of dimers
of each core variant by SDS^PAGE and Western blot. After 20 min
incubation at room temperature, the reactions were stopped by adding
4 Wl of 50 mM EDTA and 24 Wl of the SDS-sample bu¡er without L-
mercaptoethanol. The samples were analyzed by SDS^PAGE and by
Western blotting.
2.7. Native agarose gel electrophoresis
Electrophoresis of puri¢ed particles was performed on 1.5% agarose
gels in TBE bu¡er, pH 7.6. Protein bands were stained with Coomas-
sie brilliant blue.
3. Results
3.1. Co-expression of wt and deleted C genes in E. coli
Four HBV core variants with di¡erent deletions and dis-
tinct characteristics when expressed alone [11] were chosen to
study the interaction with wt core in co-expression experi-
ments using the E. coli two-vector expression system (Table
1). Due to the di¡erent protein expression levels of the full-
length compared with the C-terminally truncated form of the
C gene [11], both forms were included in the analysis. The
synthesis of the four mutant core polypeptides expressed alone
or co-expressed with wt cores were analyzed by SDS^PAGE
and Western blotting of E. coli lysates (Table 1). The combi-
nations of short and long forms of core proteins enabled us to
easily di¡erentiate between two polypeptide forms present in
the same cell lysate.
In agreement with our previous study [11], no protein prod-
ucts could be detected for deletion variants #75/95-long, #75/
95-short and #82/111-long when expressed alone. Also, no
detection of these deleted proteins was obtained by co-expres-
sion with wt cores in the short and long form, respectively
(not shown). In contrast, for deletion mutants #86/93-long,
#86/93-short and #77/93-short e⁄cient synthesis was found
by single expression, as well as by co-expression with wt cores
in both forms. Interestingly, the synthesis and solubility of
#77/93-long were markedly enhanced by co-expression of
long or short wt-core proteins. In most cases of successful
Fig. 1. Constructs for E. coli expression/co-expression of wt and de-
leted C genes in long (a) and short (b) forms. BglII and BglII/Kpn2I
fragments from cloned full-length genomes of HBV mutants were
used to substitute the corresponding fragments in pHBc3 and pT31,
as described previously [11]. Using PvuII and NaeI restriction sites,
deleted C genes in both short and long forms were cloned (along
with Ptrp) into pREP4.
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co-expression both wt and deleted proteins were detected in
comparable amounts in crude E. coli lysates (not shown).
Only in the case of the co-expression variant #77/93-long
with wt-long or -short, the deleted core polypeptide was de-
tected in lower amounts in comparison to the wt. An addi-
tional approach was chosen to examine whether these proteins
interact on the level of homo- or heterodimers to form mosaic
particles.
Although both #86/93 and #77/93 variants could be used
for further investigations concerning the possible formation of
mosaic core particles, variant #77/93 was chosen for the fol-
lowing reasons: (i) during a period of 2 years #77/93 remained
the major C gene deletion variant in sera and liver of an
immunosuppressed renal transplant patient with severe liver
disease, whereas #86/93 represented only a minor variant
from the same patient; (ii) the synthesis of #77/93-long was
improved in the presence of wt cores; (iii) the monoclonal
antibody C1-5, recognizing aa residues 78^83 absent in #77/
93 (but not in #86/93), should allow the immunoprecipitation
of putative mosaic particles by the recognition of their wt
constituents.
3.2. Puri¢cation and immunoprecipitation of mosaic core
particles
To identify putative mosaic particles by an immunoprecipi-
tation approach using the monoclonal antibody C1-5, four
combinations of sucrose gradient puri¢ed co-expression prod-
ucts were studied: #77/93-long+wt-long, #77/93-short+wt-
long, #77/93-long+wt-short, #77/93-short+wt-short. In addi-
tion, expression products of #77/93-short alone as well as of
the combination of wt core-short+wt-long were included as
controls. Due to the di¡erences in molecular weight of the
short and long forms of the core protein, the used combina-
tions should facilitate the di¡erentiation between core poly-
peptides by Western blotting.
After sucrose gradient puri¢cation, particle formation of
#77/93+wt co-expression products in comparison to wt par-
ticles was con¢rmed by electron microscopy. Because no ob-
vious quantitative or qualitative di¡erences have been ob-
served, Fig. 2 shows only two examples of particles derived
from #77/93-short+wt-long or #77/93-long+wt-long co-ex-
pression variants.
All sucrose gradient fractions were analyzed for the content
of wt and deleted core polypeptides, and only particle-con-
taining fractions showing the highest antibody-reactivity in
Western blot analysis (Fig. 3a) were loaded onto protein A-
Sepharose CL-4B coupled with C1-5 antibody. Antibody-
bound and -unbound material were analyzed by SDS^
PAGE and by immunoblotting (Fig. 3b). Only wt and mosaic
particles consisting of #77/93+wt polypeptides could be re-
tained by the antibody. As expected, the #77/93-short variant
alone was found in the concentrated unbound material (Fig.
Table 1
Synthesis and assembly-competence of deleted core polypeptides as
detected by single expression or by co-expression with wt core
Deletion variant Expressed alone Co-expressed with wt
cores
synthesis assembly synthesis assembly
#86/93-long +++ +++ +++ +++
#86/93-short +++ +++ +++ +++
#77/93-long + 3 +++ +++
#77/93-short +++ + +++ +++
#75/95-long 3 3 3 3
#75/95-short 3 3 3 3
#82/111-long 3 3 3 3
Co-expression experiments were performed with four distinct core
deletion variants exhibiting di¡erent levels of synthesis and self-as-
sembly, when expressed alone. Deletion variants are designated ac-
cording to the positions of aa deleted. Levels of synthesis are shown
as: +++, strong, high solubility; +, low, poor solubility as com-
pared to wt core protein; 3, no protein detectable. Assembly as de-
termined by electron microscopy was scored as: +++, level similar
to wt; +, traces of capsids; 3, no detectable capsids.
Fig. 2. Electron microscopy of puri¢ed core particles derived from (a) #77/93-short+wt-long and (b) #77/93-long+wt-long co-expression. Bar:
50 nm.
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3b, left). Antibody-bound co-expression products of all four
combinations of wt and #77/93 contained both wt and deleted
polypeptides (Fig. 3b, right). This indicates that in all cases of
co-expression at least a part of the puri¢ed particles represents
mosaic ones. No obvious di¡erences in the ratios of wt to
deleted proteins were detected when precipitates were com-
pared with original sucrose gradient fractions (Fig. 3a).
To analyze co-expression products for the presence of dif-
ferent types of particles as wt, mutant and mosaic particles,
respectively, the same sucrose gradient samples were applied
to native agarose gel electrophoresis (Fig. 4). To test whether
this method is suitable to distinguish between di¡erent types
of particles contained in a mixture, puri¢ed wt-short particles
were mixed with puri¢ed particles derived from co-expression
(#77^93-short+wt-short) and included as control. The appear-
ance of two distinct bands (Fig. 4, lane 8) proved the feasi-
bility of this method to di¡erentiate between two kinds of
particles. In contrast to the arti¢cial mixture, particles ob-
tained as a result of co-expression were characterized by
slightly di¡use, but de¢nite bands with di¡erent electropho-
retic mobility in comparison to each other (Fig. 4, lanes 3^7)
and to sharp distinct bands of wt core particles (Fig. 4, lanes
1, 2). The higher mobility of the wt-long particles in compar-
ison to their short counterparts could be attributed to di¡er-
ent particle surface charges. Because no wt-corresponding
bands have been observed in lanes of co-expression particles
(Fig. 4, lanes 3^7) it is supposed that particles derived from
Fig. 3. Mosaic structure of core particles consisting of wt and #77/93 polypeptides, as shown by immunoprecipitation with the monoclonal
antibody C1-5. (a) Western blot of sucrose gradient fractions subjected to precipitation. Numbers below the lanes correspond to the numbers
of appropriate fractions (fraction 1 has the highest density). The speci¢c protein product of #wt-long was represented by two bands, the lower
of them probably representing a degradation product. (b) SDS^PAGE and Western blotting of cores after binding to C1-5-coupled Sepharose
CL-4B: antibody-bound (right) and -unbound (left) material.
Fig. 4. Native agarose gel electrophoresis of puri¢ed mosaic core
particles obtained after expression/co-expression of wt and deleted C
genes.
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co-expression are rather a mixture of mosaic ones. Whether
such mixtures contain mosaic particles consisting exclusively
of wt-homodimers as well as of homodimers of deleted pro-
teins or/and of heterodimers remained unclear.
3.3. Formation of homo- and heterodimers during co-expression
of wt and #77/93
To characterize the composition of dimers forming mosaic
particles, the latter were disrupted under non-reducing condi-
tions and subjected to SDS^PAGE and immunoblotting (Fig.
5). To achieve a stable dimer formation, one portion of each
kind of puri¢ed particle was oxidized to ¢x intermolecular
disul¢de bridges between monomers. The best dimer separa-
tion was achieved for #77/93-short when it was co-expressed
with wt-long or wt-short. For these two cases, dimer-corre-
sponding bands were cut from PAGE and the proteins were
eluted and analyzed by immunoblotting. Preliminary experi-
ments showed the presence of heterodimers in addition to
both homodimeric forms in the particles (data not shown
here).
4. Discussion
HBV core particles, like other icosahedral shells, are built
from homodimers as basic structural subunits [7]. The dimers
are stabilized by a hydrophobic protein core, which is highly
conserved among human HBV variants. There are a few re-
ports on the interaction of diverse core monomers derived
from di¡erent hepadnaviruses or structurally changed by in-
sertions of foreign epitopes. Using the Xenopus oocyte expres-
sion system it was shown that co-injection of HBV core tran-
scripts with woodchuck hepatitis virus or ground squirrel
hepatitis virus core transcripts leads to the formation of hy-
brid particles consisting preferentially of homodimers of core
polypeptides from di¡erent hepadnaviruses [21]. The forma-
tion of mosaic particles, where one of the constituents is rep-
resented by a C-terminally modi¢ed variant of the initial par-
ent monomer (‘helper’), was recently shown for HBV cores
[22] and for RNA phage QL capsids [23]. Such recombinant
mosaic particles are proposed to be novel carriers for vaccine
and gene therapy purposes [3,4]. However, it remained unclear
whether such mosaic particles are composed of homodimers
or/and heterodimers.
A broad spectrum of natural C gene deletion variants co-
existing with the wt, was isolated from HBV-infected patients
[8,10,11,13]. Under immunosuppression in renal transplant
patients virus variants carrying in-frame deletions in the cen-
tral region of the C gene seem to have a selective advantage
and their accumulation correlates with the severity of liver
disease ([8,9,11] and unpublished results). However, such C
gene deletion variants have also been detected for non-immu-
nosuppressed chronic carriers without an evident association
with the outcome of the disease [10]. It has been documented
that mutated core polypeptide variants can interfere with the
wt virus in hepatoma-derived cell lines. Thus, C-terminally
modi¢ed cores of HBV [24] and duck HBV [25^28] are able
to inhibit viral replication and are suggested as potential anti-
viral agents.
Here, the possible interference of wt and deleted core poly-
peptides within the same cell was studied. The E. coli system
was chosen for the expression of deleted C genes, since it
ensures highly e⁄cient synthesis [15,16] and correct folding
and self-assembly [29,30] of recombinant cores. Moreover,
some core mutants unable to assemble in human hepatoma
cells revealed assembly competence in E. coli [31]. Short forms
(aa 1^144) of both wt and deleted core proteins were included
in the investigation, as C-terminal aa 145^183 are dispensable
for self-assembly [32,33]. As we have shown previously for the
#77/93 variant, a much better protein synthesis was obtained
for expression of the short form [11] (Table 1).
An e⁄cient two-vector system was established allowing the
co-expression of wt and deleted core proteins in E. coli result-
ing in the formation of mosaic core particles at least in the
case of the #77/93 deletion variant. The formation of mosaic
particles was con¢rmed by immunoprecipitation using a
monoclonal antibody recognizing the aa sequence 78^83
present in the wt polypeptide. Native agarose gel electropho-
resis of puri¢ed particles was carried out to show whether one
or di¡erent types of particles are formed during co-expression.
The more di¡use bands in the case of mosaic particles in
Fig. 5. Western blot of core-protein products obtained after disruption of puri¢ed wt and mosaic core particles under non-reducing conditions
with (‘+’) or without (‘3’) prior oxidation by Cu2. Products with dimer-corresponding molecular weight are marked with arrowheads.
FEBS 23955 21-7-00
P. Preikschat et al./FEBS Letters 478 (2000) 127^132 131
comparison to wt particles indicates the formation of mosaic
particles with varying ratios of wt and deleted polypeptides,
rather than of heterogeneous mixtures of di¡erent types of
exclusively wt, mutant or mosaic particles.
Moreover, to investigate the dimer content, particles were
disrupted under non-reducing conditions. Besides homo-
dimers formed between wt (long or short) and the #77/93-
short polypeptides, there is also preliminary evidence for the
presence of heterodimers in mosaic particles. It can be specu-
lated, that the #77/93 polypeptide is rescued by wt ‘helper’
core from degradation or from segregation into insoluble frac-
tions. The wt homodimeric form was detected exclusively only
in the case of #77/93-long+wt-short. This may be due to the
small content of the deletion variant within these particles. In
addition, the oxidation of dimers containing long monomers
leads to oligomerization due to the interactions of C-terminal
Cys183 residues [5]. To avoid this, it will be necessary to re-
place the Cys183 by another amino acid residue.
One can speculate that the implication of the #77/93 deleted
core polypeptide in the assembly process via interaction with
the wt partner could contribute to liver destruction through
intracellular accumulation of aberrant, cytopathic core par-
ticles, or by interference with substantial cellular proteins.
However, for core mutants with longer deletions (#75/95,
#82/111) such rescue phenomenon in the presence of wt poly-
peptides was not observed at least in E. coli. Obviously, this
re£ects the rather complex situation in liver pathogenesis of
immunosuppressed renal transplant patients. Nevertheless, the
generation of the two-vector expression system opens a way
for more extensive investigations of the mechanisms involved
in virus assembly.
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